Michael Lutz
Chief Executive Officer presso Iota Sciences Ltd.
Profilo
Michael Lutz holds the position of Executive Chairman for NTP Nano Tech Projects SRL and Chief Executive Officer & Director at Iota Sciences Ltd.
Dr. Lutz is also on the board of 2cureX ApS and Noscendo GmbH.
Dr. Lutz previously held the position of Managing Director at Lophius Biosciences GmbH and Chief Executive Officer & Managing Director at HepaRegeniX GmbH.
Dr. Lutz received a doctorate from Swiss Federal Institute of Technology.
Posizioni attive di Michael Lutz
Società | Posizione | Inizio |
---|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Director/Board Member | 01/01/2020 |
Noscendo GmbH
Noscendo GmbH Medical SpecialtiesHealth Technology Noscendo GmbH is a diagnostics company, which engages in the identification and assessment of bloodstream-associated pathogens and other infections. It offers logistics, sample preparation, sequencing, data analysis, and reports. The company was founded by Philip Stevens, Silke Grumaz and Kai Sohn and is headquartered in Duisburg, Germany. | Director/Board Member | - |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | Chairman | 15/03/2023 |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | Chief Executive Officer | 03/08/2023 |
Precedenti posizioni note di Michael Lutz
Società | Posizione | Fine |
---|---|---|
2CUREX AB | Director/Board Member | 01/02/2023 |
HepaRegeniX GmbH
HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Chief Executive Officer | - |
Lophius Biosciences GmbH
Lophius Biosciences GmbH Medical/Nursing ServicesHealth Services Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany. | Chief Executive Officer | - |
Formazione di Michael Lutz
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
2CUREX AB | Health Technology |
Aziende private | 6 |
---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
Lophius Biosciences GmbH
Lophius Biosciences GmbH Medical/Nursing ServicesHealth Services Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany. | Health Services |
HepaRegeniX GmbH
HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Commercial Services |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | Technology Services |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | Commercial Services |
Noscendo GmbH
Noscendo GmbH Medical SpecialtiesHealth Technology Noscendo GmbH is a diagnostics company, which engages in the identification and assessment of bloodstream-associated pathogens and other infections. It offers logistics, sample preparation, sequencing, data analysis, and reports. The company was founded by Philip Stevens, Silke Grumaz and Kai Sohn and is headquartered in Duisburg, Germany. | Health Technology |